of additional probes into regions of tumor that do not reach critical temperatures can be performed to control the shape of the iceball. Thermocouple probes can be placed at critical locations; however, we prefer to use imaging to assess tissue temperatures. While a thermocouple probe provides a single point measurement, imaging displays volumetric information.
Imaging guidance for cryoablation
Unlike RF ablation, cryoablation allows intraprocedural monitoring. The iceball can be seen on all cross sectional imaging modalities including ultrasonography (US), CT, and MRI. This permits better tumor coverage, and prevents injury to adjacent organs. Although ultrasound can be used to guide cryoablation (14) , posterior acoustic shadowing limits visualization. CT can be used to visualize the entire iceball. Frozen tissue is hypodense relative to unfrozen tissue (15) . The iceball is visible on all MRI sequences as a signal void, and can be differentiated from tumors, which are typically T2-hyperintense.
Clinical applications Cryoablation in liver tumors
Patients with primary and metastatic liver tumors (Fig. 3 ) who are not candidates for surgical resection due to comorbidities or advanced age can be treated with percutaneous cryoablation. Although most studies have included patients with liver metastases from colorectal carcinoma, liver metastases from other primaries also can be treated. Local tumor recurrences are more frequent following cryoablation of large tumors (>3 cm) and tumors located close to large vessels, which can cause a "thermal sink" effect. The flowing blood within the lumen of the adjacent vessel may prevent temperature from decreasing to lethal levels. This may result in inadequate ablation, thus increasing the risk of tumor recurrence in this region. Using CT or MRI, dome lesions can be treated with cryoablation without significant pulmonary complications. The iceball can be extended 1-2 cm into the lungs. After treating such a tumor, we have observed atelectasis and effusion, but not pneumothorax.
When a tumor involves a large volume of normal liver parenchyma, myoglobin may increase within the serum, which typically returns to normal within a couple of days. Severe myoglobinemia, particularly in the presence of underlying poor renal function, may cause acute renal failure. Therefore, adequate urinary output should be maintained. We alkalinize urine with intravenous sodium bicarbonate if the serum myoglobin level is above 1000 ng/mL. Following a cryoablation procedure, platelet count should be checked because ablation of large liver tumors rarely may cause severe thrombocytopenia (2, 6, 14, 16).
to cold than are others. While melanocytes are one of the most sensitive cell types, collagen and elastin fibers are more resistant (4, 7, 13) . The fact that connective tissue is relatively resistant to freezing maintains the safety profile of cryoablation.
Cryoablation technique
We use an argon-based cryoablation unit (Cryohit; Galil Medical, Yokneam, Israel) ( Fig. 1) . High-pressure argon gas is circulated through the lumen of thin probes because of its low viscosity. Low pressure within the lumen of the cryoprobe results in rapid expansion of argon gas, which creates a very low temperature (JouleThompson principle) (4). This low temperature (well below -100 °C) creates an iceball around the tip of the cryoprobe (Fig. 2) .
The thaw is generally passive, as slow thawing maximizes cell death. Helium gas is circulated at the end of the thaw to accelerate cryoprobe removal. Multiple probes can be used simultaneously to ablate larger lesions, or lesions in different locations. The temperature at the margin of the ice ball is 0 °C. Lethal temperatures (-20 to -50 °C) are found 5 mm inside the iceball edge. Therefore, the iceball needs to be extended beyond the tumor border (depending on the organ being ablated) for complete ablation. Adjustment of the amount of argon flow to specific probes, and placement 
Figure 2.
Iceball formation at the tip of cryoprobes (Galil Medical, Yokneam, Israel). The image was taken during the procedure just before probe insertion. Each probe must be tested in sterile saline immediately before and after the procedure to confirm adequacy of function, and to exclude gas leakage.
Cryoablation in renal tumors
Surgery is the standard treatment for renal cell carcinoma. However, percutaneous ablation provides a less invasive alternative. Percutaneous cryoablation has proven to be a safe procedure with relatively few complications (4) . Patients who need nephron-sparing treatment include those with renal insufficiency or von Hippel-Lindau disease. In addition, patients with limited life expectancy are especially good candidates for this technique.
Peripheral, posteriorly situated tumors arising from the inferior pole of the kidney are ideal for ablation; central tumors also can be ablated without injury to the collecting system. Attention should be paid when ablating medially situated lower-pole tumors, to prevent injury to the ureter. Treating anteriorly located tumors carries a risk of bowel injury; however, external manual compression on an open interventional MRI unit can be applied to displace adjacent bowel loops (17) . Alternatively, hydrodissection by instilling sterile saline through a separate needle can be attempted to prevent freezing-related bowel injury (Fig. 4) .
Cryoablation in lung tumors
Lung cancer is the leading cause of cancer-related death in both men and women. The non-small cell (NSCLC) type accounts for 80% of cases. Surgery is the standard of care for early stage (stage I/II) NSCLC, and provides the best opportunity for cure. Unfortunately, the majority of NSCLC patients presenting with stage I/II disease are not surgical candidates due to co-morbid cardiopulmonary disease with insufficient reserve to withstand lobectomy (18, 19) . Traditionally, these patients have been treated with systemic chemotherapy and/or external beam radiation with a high local recurrence rate and poor long-term survival (20, 21) .
Image-guided thermal ablation techniques may be an alternative for patients with stage I disease not amenable to surgery. Although the first case was published in 2000, radiofrequency ablation of lung neoplasms has found widespread use, and is currently the most commonly utilized thermal ablation method (22) . Radiofrequency ablation has been shown to be effective and safe to treat various stages of NSCLC and pulmonary metastases limited to the lung. Preliminary studies suggest that cryoablation has potential for this indication (7, 23, 24) . Cryoablation may be preferable to RF ablation for tumors adjacent to mediastinal structures since cryoprobes can be placed close to the mediastinal and hilar vessels to intensify the freezing and to avoid perfusion-mediated heating without fear of vessel damage, because the collagenous architecture of the vessel wall is preserved (24) .
Soft tissue and bone tumors
Cryoablation can be used effectively for local tumor control and pain palliation, and in patients with metastatic soft tissue and bone tumors (25) . A single ablation session is effective in most patients, and is well tolerated, because cryoablation causes mild or insignificant pain compared with other ablation techniques, and provides long-lasting pain relief (Fig. 5) . Cryoablation can be selected particu- larly as an ablation method to treat tumors adjacent to important critical structures such as the spinal cord, sciatic nerve, and gastrointestinal and urinary organs, due to visibility of the iceball on imaging, thus allowing intraprocedural monitoring.
Cryoablation in the adrenal gland
Although percutaneous ablation of primary adrenal cortical carcinomas and hyperfunctioning adenomas has been reported, our experience with the adrenal gland also includes metastatic neoplasms (17, 26) . The adrenal gland is a common site of metastases. Metastases limited to the adrenal gland occur particularly from renal cell carcinoma and small cell lung cancers. Minimally invasive percutaneous treatment of adrenal gland metastases with either chemical or heat-based ablation methods have been described (26) (27) (28) . The adrenal gland is surrounded by several critical organs, especially on the left side. We prefer cryoablation to treat isolated adrenal gland metastases due to intraprocedural monitoring capability with this technique.
We premedicate our patients with alpha and beta-blockers prior to the ablation, to prevent episodes of hypertensive crises during ablation, which typically occur during thawing. In our experience, hypertensive crises may occur if the remaining normal adrenal gland tissue is affected by the ablation; hypertensive crises usually are not observed if the entire adrenal gland is replaced by tumor, which generally is seen only when the tumor size exceeds 4 cm (17) .
Cryoablation in other tumors
Virtually any local solid tumors that are not responding to chemotherapy can be treated with percutaneous cryoablation. These tumors include limited retroperitoneal lymphadenopathy from completely treated primaries such as renal cell carcinoma, focal intraperitoneal soft tissue metastases of ovarian carcinoma with no disease elsewhere, and recurrent rectal adenocarcinoma limited to the presacral region (4, 7, 11) .
Conclusion
Tumors of virtually any shape can be treated with cryoablation, due to the ability to place and activate multiple cryoprobes simultaneously; the ability to control cryogen gas to individual cryoprobes allows control b a d c Figure 5 . a-d. A 60-year-old woman with metastatic renal cell carcinoma and painful metastasis to the right iliac bone is seen (arrowhead) on this contrast-enhanced, fat-suppressed, T1-weighted spoiled gradient echo MR image (a). The patient was referred to our department for imageguided percutaneous ablation for pain palliation. MR-imaging-guided cryoablation was performed using two B sphere cryoprobes (arrowhead) as seen on this sagittal MR image (b). The patient's pain subsided significantly following the procedure. In addition, follow-up axial MRI (c) performed one day after ablation showed good coverage of the tumor (arrowhead). There was no evidence of tumor recurrence (arrowhead) on follow up bone scan (d).
of iceball margins during treatment. While the former feature of cryoablation allows better tumor coverage, the latter helps to prevent injury of adjacent organs. Therefore, cryoablation can be used successfully to treat tumors of various organs. CT and MRI can be used to visualize the iceball intraprocedurally to maximize the chance of treating the tumor completely and to avoid complications.
